Haemonchus contortus resistance in straightbred and crossbred Barbados Blackbelly sheep.
Resistance to Haemonchus contortus infection was studied in two experiments conducted with 52 lambs of widely different genetic background. Breed groups compared were: Dorset (D), Barbados Blackbelly (B), Dorset x Blackbelly (D x B), Suffolk x Blackbelly (S x B), Suffolk x Dorset x Blackbelly (S x D x B,[1/4 B]) and nonBlackbelly (NB, D and S). In each experiment, lambs were raised on concrete from birth and were essentially parasite free until infective larvae were administered. In Exp. 1, D x B, S x D x B and D wether lambs approximately 3 months old were infected with a standard dose of invective larvae estimated to be 98% H. contortus. D x B lambs had a longer (P < .05) prepatency period and, at necropsy 17-day postinfection, had a higher (P < .05) percentage of female parasites classified as immature than did the other breed groups. These data showed that the development of H. contortus larvae was inhibited in D x B host animals. In Exp. 2, B, D x B, S x B and NB ewe and wether lambs approximately 4 months old were treated with three sensitizing doses of H. contortus larvae. These were followed by a challenge infection. On the basis of fecal egg counts (eggs per gram feces, EPG), there was no evidence that the challenge infection induced a self-cure reaction in any breed group. All lambs with B breeding had significantly higher Hb levels at the end of the experiment than did NB lambs. b and S x B lambs had higher (P < .05) Hb levels than the D x B lambs, and B lambs had the highest (P < .05) mean corpuscular hemoglobin concentrations. Five days after the challenge infection, B, D x B and S x B lambs also had significantly higher white blood cell levels than did NB lambs. Significant sex differences were also observed in Exp. 2. Ewe lambs had lower final EPG levels, higher preinfection and postinfection Hb levels and higher maximum postinfection cosinophil levels. Breed x sex interactions for these parameters were not significant.